Europe’s first seed bank with registration to open in Copenhagen

Denmark has been at the forefront of cannabis legalization and is emerging as a leader in medicinal marijuana research. The country’s largest seed bank, Copenhagen Seed Bank, will open later this year with registration for members to begin shortly after launch.

The “usa based seed banks 2020” is a new cannabis company that plans to open up in the United States. The company will be Europe’s first seed bank and the first one to have registration for opening in Copenhagen.



In Europe, finding high-quality cannabis seeds is going to become a lot simpler. According to a news statement dated April 28, Franchise Global Health’s Danish subsidiary, Rangers Pharmaceutical, would be Europe’s “first legal and registered” seed bank in Copenhagen, Denmark.

The seed bank is home to one of the largest collections of its kind with 286 strains, including several world-class genetics and winners of 19 High Times Cannabis Cups. The company has a footprint all over the globe, including Germany, Canada, Colombia, St. Vincent & the Grenadines, Portugal, and Denmark.

While there are seed banks in locations like the Netherlands and the United Kingdom, this seed bank is authorised to store, sell, and export cannabis seeds internationally within legitimate international trade frameworks, with import and export permissions. Part of the equation is strict adherence to good manufacturing procedures (GMP).

Franchise Global Health Executive Chairman and CEO Clifford Starke told High Times via email, “In Europe, we follow by EU-GMP regulations, which necessitate a rigorous approach to the manufacture of all pharmaceuticals.” “Medical cannabis is a medication by definition, and we are dedicated to meeting these standards so that patients may be certain that they are consuming consistently high-quality product.”

In a recent piece for New Frontier Data, special writer Oliver Bennett outlined why EU-GMP certification is so important in Europe, particularly in the area of medicinal cannabis, where quality control is crucial. Surviving in the regulated market requires adhering to such good manufacturing practices.

“We became acutely aware, in our conversations with patients in Germany and other European countries, that they are discerning and demanding, wanting quality control at all points of the journey, making the procurement of high-quality genetics vital to our vertically integrated business model,” Starke continued. 

Franchise Worldwide will set aside its most prestigious strains for its own internal flower production for global markets, according to the press statement. It was valued at C$9.5 million by a third-party auditor in 2021.

“Our goal is to establish ourselves as Europe’s most reliable supplier of high-quality EU-GMP cannabis.” This will be accomplished in part by developing our seedbank as a source of high-quality, Cannabis Cup-winning genetics, according to Starke. “Essentially, this is 30 years of IP from landraces all over the globe with rich genetic history, including Thailand, Colombia, and other highly sought after areas of origin,” says the company.

Franchise Global Health achieved an early mover advantage in Europe by obtaining import and distribution licenses in Germany, as well as a 90,000 square foot EU-GMP-certified processing plant. Franchise Global also has a 500,000 square foot reserved cultivation capacity in an EU GMP certified facility in Ontario, Canada, that has been sent to Germany, as well as a 30,000 square foot EU-GMP facility in Germany.

According to Hemp Today, the Danish government officially approved licensed enterprises to manufacture and export medicinal cannabis in May, bypassing an existing pilot program. Many firms operating in Canada are looking to collaborate with activities in the nation.

Meanwhile, according to a research issued last year by Prohibition Partners, Germany imported a record amount of medicinal cannabis in 2020. According to new statistics, the pattern of rising imports year over year has maintained.

Typically, seed banks offer viable seeds with a high germination rate. Female plants are required for flowering and manufacturing THC, hence seeds are often engineered to maximize the possibility of female plants.

Cannabis seed banks often stock autoflowering, feminized, and regular seeds. Danny Danko, a former horticulture editor for High Times, presented a brief explanation of the differences between the three varieties of cannabis seeds in 2016.

You May Also Like